BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 34663403)

  • 21. [Significance of selective neck dissection in patients with cN0 thyroid carcinoma].
    Li ZJ; An CM; Yan DG; Zhang XW; Zhang ZM; Xu ZG; Tang PZ
    Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):783-6. PubMed ID: 24378103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Exploration of lymph node metastasis and appropriate lymph node dissection modes in patients with clinical stage I non-small cell lung cancer].
    Zhang Z; Mao Y; He J; Gao S; Cheng G; Liu X; Fang D; Li J; Wang Y; Wang D; Mu J; Xue Q; Gao Y; Zhao J; Zhang L; Huang J; Wang B; Ding N
    Zhonghua Zhong Liu Za Zhi; 2014 Jul; 36(7):536-40. PubMed ID: 25327661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk Factors for Predicting Occult Lymph Node Metastasis in Patients with Clinical Stage I Non-small Cell Lung Cancer Staged by Integrated Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Kaseda K; Asakura K; Kazama A; Ozawa Y
    World J Surg; 2016 Dec; 40(12):2976-2983. PubMed ID: 27456499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Impact of the examined number of lymph nodes at N1 station on the prognosis of patients with pT1-3N0M0 non-small cell lung cancer].
    Wang GX; Li T; Xu SB; Wang J; Xiong R; Xu MQ; Xie MR
    Zhonghua Zhong Liu Za Zhi; 2022 Feb; 44(2):155-159. PubMed ID: 35184459
    [No Abstract]   [Full Text] [Related]  

  • 25. Lymph node metastasis risk factors in clinical stage IA3 lung adenocarcinoma.
    Zheng Y; Ju S; Huang R; Zhao J
    J Cancer Res Ther; 2023 Feb; 19(1):34-38. PubMed ID: 37006040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of maximum standardized uptake value with occult mediastinal lymph node metastases in cN0 non-small cell lung cancer.
    Lin JT; Yang XN; Zhong WZ; Liao RQ; Dong S; Nie Q; Weng SX; Fang XJ; Zheng JY; Wu YL
    Eur J Cardiothorac Surg; 2016 Nov; 50(5):914-919. PubMed ID: 27113090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor-to-liver standard uptake ratio using fluorine-18 fluorodeoxyglucose positron emission tomography computed tomography effectively predict occult lymph node metastasis of non-small cell lung cancer patients.
    Shi YM; Niu R; Shao XL; Zhang FF; Shao XN; Wang JF; Wang XS; Liu B; Yu WJ; Wang YT
    Nucl Med Commun; 2020 May; 41(5):459-468. PubMed ID: 32187163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathologic predictors of metastasis of different regional lymph nodes in patients intraoperatively diagnosed with stage-I non-small cell lung cancer.
    Zhao F; Zhen FX; Zhou Y; Huang CJ; Yu Y; Li J; Li QF; Zhu CX; Yang XY; You SH; Wu QG; Qin XY; Liu Y; Chen L; Wang W
    BMC Cancer; 2019 May; 19(1):444. PubMed ID: 31088404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of predictive factors for postoperative survival for non small cell lung carcinoma patients with unexpected mediastinal lymph nodes metastasis.
    Wang S; Zhou W; Zhang H; Zhao M; Chen X
    Thorac Cardiovasc Surg; 2014 Mar; 62(2):126-32. PubMed ID: 23585223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nomogram based on prognostic nutrition index and Chest CT imaging signs predicts lymph node metastasis in NSCLC patients.
    Chen M; Yang Y; He C; Chen L; Cheng J
    J Xray Sci Technol; 2022; 30(3):599-612. PubMed ID: 35311733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive value of primary fluorine-18 fluorodeoxyglucose standard uptake value for a better choice of systematic nodal dissection or sampling in clinical stage ia non--small-cell lung cancer.
    Li X; Zhang H; Xing L; Xu X; Xie P; Ma H; Zhang L; Chen M; Sun X; Xu W; Chen L; Yu J
    Clin Lung Cancer; 2013 Sep; 14(5):568-73. PubMed ID: 23835164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mediastinal lymph node metastasis pattern in clinically N0 non-small-cell lung cancer patients who underwent surgical resection.
    Krdzalic G; Mesic D; Iljazovic E; Brkic S; Krdzalic A; Ramic N; Aljic Z; Musanovic N
    Med Arh; 2010; 64(6):332-4. PubMed ID: 21218749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Construction and verification of lymph node metastasis model of cN0 stage thyroid micropapillary carcinoma and discussion of surgical methods].
    Yang R; Zhang S; Huang T; Ming J; Yang P; Zhu J; Qu F
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2021 Feb; 35(2):137-140. PubMed ID: 33540995
    [No Abstract]   [Full Text] [Related]  

  • 34. Prediction of lymph node metastasis of clinical stage IA non-small cell lung cancer based on the tumor volume doubling time.
    Nakahashi K; Shiono S; Nakatsuka M; Endo M
    Surg Today; 2022 Jul; 52(7):1063-1071. PubMed ID: 35044521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors of lymph node metastasis in patients with non-small cell lung cancer ≤ 2 cm in size: A monocentric population-based analysis.
    Yu X; Li Y; Shi C; Han B
    Thorac Cancer; 2018 Jan; 9(1):3-9. PubMed ID: 29034994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of three measurements on computed tomography for the prediction of less invasiveness in patients with clinical stage I non-small cell lung cancer.
    Matsuguma H; Oki I; Nakahara R; Suzuki H; Kasai T; Kamiyama Y; Igarashi S; Mori K; Endo S; Yokoi K
    Ann Thorac Surg; 2013 Jun; 95(6):1878-84. PubMed ID: 23618519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A clinicopathological study of resected non-small cell lung cancers 2 cm or less in diameter: a prognostic assessment.
    Shi CL; Zhang XY; Han BH; He WZ; Shen J; Chu TQ
    Med Oncol; 2011 Dec; 28(4):1441-6. PubMed ID: 20661664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of lymph node involvement with the prognosis of pathological T1 invasive non-small cell lung cancer.
    Zhang YK; Chai ZD; Tan LL; Wang ZY; Chen ZJ; Le HB; Zhu WY
    World J Surg Oncol; 2017 Mar; 15(1):64. PubMed ID: 28302176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Segment Location and Ground Glass Opacity Ratio Reliably Predict Node-Negative Status in Lung Cancer.
    Zhang Y; Fu F; Wen Z; Deng L; Wang S; Li Y; Chen H
    Ann Thorac Surg; 2020 Apr; 109(4):1061-1068. PubMed ID: 31863756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk analyses of N2 lymph-node metastases in patients with T1 non-small cell lung cancer: a multi-center real-world observational study in China.
    Chen B; Xia W; Wang Z; Zhao H; Li X; Liu L; Liu Y; Hu J; Fu X; Li Y; Xu Y; Liu D; Yang H; Xu L; Jiang F
    J Cancer Res Clin Oncol; 2019 Nov; 145(11):2771-2777. PubMed ID: 31428933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.